Telbivudine for the treatment of hepatitis B disease

Author： Tsunoda Shirley M   Hassanein Tarek  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.6, 2008-11, pp. : 517-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B

By Han Steven-Huy B  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 511-519

Informa Healthcare

Access to resources Recommend Favorite

Telbivudine for Chronic Hepatitis B. A Review

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 4, 2008-10 ,pp. : 245-248

Bentham Science Publishers

Access to resources Recommend Favorite

Telbivudine myopathy in a patient with chronic hepatitis B

By Wang Min  

International Journal of Clinical Pharmacy, Vol. 34, Iss. 3, 2012-06 ,pp. : 422-425

Springer Publishing Company

Access to resources Recommend Favorite

Telbivudine triumphs over opponents in hepatitis B

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Telbivudine making a global impact on hepatitis B

By  

Inpharma, Vol. 1, Iss. 1525, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite